CN101804189B - Drug for treating primary dysmenorrhea - Google Patents
Drug for treating primary dysmenorrhea Download PDFInfo
- Publication number
- CN101804189B CN101804189B CN201010149096XA CN201010149096A CN101804189B CN 101804189 B CN101804189 B CN 101804189B CN 201010149096X A CN201010149096X A CN 201010149096XA CN 201010149096 A CN201010149096 A CN 201010149096A CN 101804189 B CN101804189 B CN 101804189B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- drug
- rhizoma
- dysmenorrhea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 35
- 206010013935 Dysmenorrhoea Diseases 0.000 title claims abstract description 34
- 229940079593 drugs Drugs 0.000 title abstract description 24
- 241000218176 Corydalis Species 0.000 claims abstract description 10
- 241000628997 Flos Species 0.000 claims abstract description 10
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 11
- 241000180649 Panax notoginseng Species 0.000 claims description 11
- 210000000582 Semen Anatomy 0.000 claims description 9
- 239000012567 medical material Substances 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 235000014375 Curcuma Nutrition 0.000 claims description 2
- 240000002123 Curcuma aromatica Species 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 9
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 235000010894 Artemisia argyi Nutrition 0.000 abstract 1
- 241001249158 Artemisia verlotiorum Species 0.000 abstract 1
- 235000016855 Biancospino Nutrition 0.000 abstract 1
- 244000306301 Caesalpinia sappan Species 0.000 abstract 1
- 235000015162 Caesalpinia sappan Nutrition 0.000 abstract 1
- 240000004499 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 244000163122 Curcuma domestica Species 0.000 abstract 1
- 235000003392 Curcuma domestica Nutrition 0.000 abstract 1
- 240000002298 Cyperus longus Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 240000000628 Cyperus rotundus Species 0.000 abstract 1
- 240000008259 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 240000004678 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 240000007329 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 235000002313 hawthorn Nutrition 0.000 abstract 1
- 235000009444 hawthorn Nutrition 0.000 abstract 1
- 235000009486 hawthorn Nutrition 0.000 abstract 1
- 235000009682 hawthorn Nutrition 0.000 abstract 1
- 235000009685 hawthorn Nutrition 0.000 abstract 1
- 235000009917 hawthorn Nutrition 0.000 abstract 1
- 235000013161 hawthorn Nutrition 0.000 abstract 1
- 235000013165 hawthorn Nutrition 0.000 abstract 1
- 235000013189 hawthorn Nutrition 0.000 abstract 1
- 235000013204 hawthorn Nutrition 0.000 abstract 1
- 235000013214 hawthorn Nutrition 0.000 abstract 1
- 235000013246 hawthorn Nutrition 0.000 abstract 1
- 235000017423 hawthorn Nutrition 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 231100000486 side effect Toxicity 0.000 abstract 1
- 235000013976 turmeric Nutrition 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 17
- 208000005171 Dysmenorrhea Diseases 0.000 description 16
- 210000004369 Blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 230000001737 promoting Effects 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 8
- 230000027758 ovulation cycle Effects 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 230000003821 menstrual periods Effects 0.000 description 5
- 230000001225 therapeutic Effects 0.000 description 5
- 210000001015 Abdomen Anatomy 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 210000001624 Hip Anatomy 0.000 description 4
- 230000000202 analgesic Effects 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 230000003203 everyday Effects 0.000 description 4
- 235000008216 herbs Nutrition 0.000 description 4
- 230000002175 menstrual Effects 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 3
- 230000000240 adjuvant Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 2
- 210000003414 Extremities Anatomy 0.000 description 2
- 210000004392 Genitalia Anatomy 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000001105 regulatory Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 230000037242 Cmax Effects 0.000 description 1
- 206010009866 Cold sweat Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 231100000614 Poison Toxicity 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 210000000952 Spleen Anatomy 0.000 description 1
- 210000002784 Stomach Anatomy 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 231100000494 adverse effect Toxicity 0.000 description 1
- 230000003110 anti-inflammatory Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000002354 daily Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000020828 fasting Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002496 gastric Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organs Anatomy 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N p-acetaminophenol Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000004083 survival Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
Abstract
The invention discloses a drug for treating primary dysmenorrhea, consisting of branch root of Chinese angelica, nutgrass galingale rhizome, sappan wood, suberect spatholobus stem, peach seed, rhizoma corydalis, red paeony root, ginger, pseudo-ginseng, Chinese mugwort leaf, hawthorn fruit, turmeric root-tuber, cassia twig and flos caryophyllata. The drug for treating primary dysmenorrheal has obvious curative effect and no toxic and side effect.
Description
Technical field
The present invention relates to a kind of Chinese herbal medicine for the treatment of primary dysmenorrhea.
Background technology
Primary dysmenorrhea is a common gynecological disease.Primary dysmenorrhea is meant that the genitals does not have organic disease, is called primary dysmenorrhea again.According to investigations, the incidence rate of primary dysmenorrhea accounts for 36.06% of dysmenorrhea.What have a strong impact on work and study accounts for 13.59%.To its treatment, doctor trained in Western medicine is emphasized pain relieving, calmness, and the nonsteroidal anti inflammatory medicine is the most frequently used Western medicine of treatment primary dysmenorrhea.Though rapid-action, erious adverse reaction, curative effect is difficult to lastingly.The effect of the existing quick-acting antalgesic of treatment by Chinese herbs dysmenorrhea, the effect that has the dysmenorrhea of preventing to show effect once more again.
Summary of the invention
The medicine that the purpose of this invention is to provide a kind of therapeutic effect good curing primary dysmenorrhea.
Medical material in the raw material of the present invention is formed and the weight portion proportioning is:
Radix Angelicae Sinensis 5-15 part, Rhizoma Cyperi 20-40 part, Lignum Sappan 5-15 part, Caulis Spatholobi 10-20 part,
Semen Persicae 5-15 part, Rhizoma Corydalis 10-20 part, Radix Paeoniae Rubra 5-15 part, Rhizoma Zingiberis Recens 10-15 part,
Radix Notoginseng 5-25 part, Folium Artemisiae Argyi 5-12 part, Fructus Crataegi 10-20 part, Radix Curcumae 3-9 part,
Ramulus Cinnamomi 3-9 part and Flos Caryophylli 3-9 part.
The weight portion proportion optimization that medical material in the raw material is formed is:
10 parts of Radix Angelicae Sinensis, 30 parts of Rhizoma Cyperis, 10 parts of Lignum Sappans, 10 parts of Caulis Spatholobis,
10 parts in Semen Persicae, 15 parts of Rhizoma Corydalis, 10 parts of Radix Paeoniae Rubra, 10 parts in Rhizoma Zingiberis Recens,
10 parts of Radix Notoginseng, 6 parts of Folium Artemisiae Argyis, 10 parts of Fructus Crataegis, 6 parts of Radix Curcumaes,
6 parts of 6 parts of Ramulus Cinnamomi and Flos Caryophyllis.
Preparation method of the present invention:
Take by weighing Radix Angelicae Sinensis, Rhizoma Cyperi, Lignum Sappan, Caulis Spatholobi, Semen Persicae, Rhizoma Corydalis, Radix Paeoniae Rubra, Rhizoma Zingiberis Recens, Folium Artemisiae Argyi, Fructus Crataegi, Radix Curcumae, Ramulus Cinnamomi and Flos Caryophylli by weight ratio, add 500 milliliters of slow fire of water and fry in shallow oil half an hour slowly, get supernatant.Other gets Radix Notoginseng 10 grams and is ground into fine powder, and other wraps stand-by.
Using method of the present invention:
A few days ago begin to take in each menstrual cycle, potion clear water decoction every day, sooner or later respectively once.Get the supernatant Radix Notoginseng powder of taking after mixing it with water when taking, serve on five days and get final product.
Solution of the present invention is based on motherland's medical science to primary dysmenorrhea and pathogenetic understanding and Therapeutic Principle, with reference to modern pharmacological research achievement, carries out the brand-new prescription of Chinese herbal medicine by theory of Chinese medical science, realizes the effective treatment to primary dysmenorrhea.
In the Chinese prescription of the present invention, Radix Angelicae Sinensis is warm in nature, sweet in the mouth, suffering, but circulation of qi promoting enrich blood, promoting blood circulation to restore menstrual flow is monarch drug; Rhizoma Cyperi property is flat, hot, and mildly bitter flavor, little sweet is the Directorate-General DG of disorder of QI, but promoting QI circulation for relieving depression, and menstruction regulating and pain relieving is monarch drug; Lignum Sappan property is flat, sweet in the mouth, salty, can separate the blood and dissolving stasis pain relieving and stimulate the menstrual flow, and is ministerial drug; Caulis Spatholobi is warm in nature, bitter in the mouth, sweet, but promoting tissue regeneration by removing blood stasis, and fluent passages through which vital energy circulates is ministerial drug; Semen Persicae is flat, bitter in the mouth, sweet, but blood circulation promoting and blood stasis dispelling is ministerial drug; Rhizoma Corydalis is warm in nature, acrid in the mouth, hardship, and the promoting the circulation of QI pain relieving of can invigorating blood circulation is ministerial drug; Radix Paeoniae Rubra cold nature, bitter in the mouth, but promoting blood circulation to remove blood stasis are ministerial drug; Rhizoma Zingiberis Recens slightly warm in nature, acrid in the mouth, it is capable to promote blood, is messenger drug; Radix Notoginseng is warm in nature, sweet in the mouth, little hardship, but the dissipating blood stasis analgesic therapy can lead to and can mend, be ministerial drug; Folium Artemisiae Argyi is warm in nature, bitter in the mouth, suffering, but the dispelling cold by warming the meridian pain relieving is messenger drug; Fructus Crataegi is warm in nature, sour in the mouth, sweet, but the circulation of qi promoting dissipating blood stasis is adjuvant drug; Radix Curcumae is cold in nature, bitter in the mouth, suffering, but regulating qi to disperse stagnation is adjuvant drug; Ramulus Cinnamomi is warm in nature, sweet in the mouth, suffering, but warming the meridian and promoting blood circulation, and dispersing cold for relieving pain is messenger drug; Warm in nature, the acrid in the mouth of Flos Caryophylli, but warming spleen and stomach for dispelling cold pain relieving are adjuvant drug., assist a ruler in governing a country mutually through dialectical prescription, organic compatibility with above-mentioned 14 flavor Chinese herbal medicine, can reach the effect that promoting flow of QI and blood, blood stasis dispelling cold expelling, pain relieving stimulate the menstrual flow, thereby realize the purpose of treatment primary dysmenorrhea.
The acute toxicity test of Chinese prescription of the present invention
One, experiment material
Animal: Kunming mouse is provided by laboratory animal room of the Capital University of Medical Sciences, and body weight is 18～22g.
Medicine: this Chinese prescription with distilled water slow fire fry in shallow oil slowly concentrate after half an hour standby.
Two, method:
Mtd test
20 of female mices, experiment the previous day, water is can't help in fasting overnight, under the condition of 20 ± 2 ℃ of room temperatures, gastric infusion twice in 24 hours, dosage is 15.0g/Kg, observes a week after the administration.
Mice in 30 minutes, because the administration volume is bigger than normal, has discomfort slightly after administration as a result, and it shows as mice and has loose bowels, back of a bow phenomenon recovers normal subsequently rapidly, and quiet, observes for two weeks continuously, mice all survives, and cuts open inspection, and naked eyes examine main inner internal organs, no abnormality seen.
Three, conclusion:
According to the requirement of Chinese medicine toxicological study, can accept maximum volume under the Cmax mice, carry out mtd test.Mice is all survivals in the observation period, do not see overt toxicity, show that this poison of drug is very little, and is clinical safe in utilization.
The clinical research data of prescription of the present invention
1. physical data
Selected 180 routine cases are and are diagnosed as the patient of primary dysmenorrhea at my gate year January in January, 2007 to 2009, and the age is between 13 years old one 42 years old.48 examples within the course of disease 1 year, 1-2 45 examples, 2-4 66 examples, 21 examples more than 4 years.Normal substantially 138 examples of menstrual cycle, period staggering 42 examples.The dysmenorrhea time is many to be main in first and second sky of menstrual onset.Once treated with Chinese and western drugs mostly, poor effect, the dysmenorrhea symptom does not improve.
2. diagnostic criteria
" the clinical research guideline of treatment by Chinese herbs dysmenorrhea " of standard reference bureau of drug administration of Ministry of Health of the People's Republic of China formulation in 1993.The women is all before and after pass through or menstrual period occur hypogastralgia, weigh down and expand, companion's soreness of waist or other discomforts, and degree is heavier so that influence the live and work quality, and the genitals does not have organic disease person on inspection.Get rid of the case standard: be secondary dysmenorrhea person after diagnosing.
3. dysmenorrhea degree standard: " the clinical research guideline of treatment by Chinese herbs dysmenorrhea " formulated according to bureau of drug administration of Ministry of Health of the People's Republic of China in 1993
Slightly: in menstrual period or obvious through front and back lower abdomen pain, companion's waist is ached, but can adhere to work, and no General Symptoms need be obeyed analgesic sometimes.The dysmenorrhea symptom integral is below 8 minutes.
Moderate: lower abdomen pain accompanies waist to ache unbearably before and after menstrual period or menstrual period, and nausea and vomiting, extremity are not warm, postpones with pain relieving measure pain.The dysmenorrhea symptom integral is at the 8-13.5 branch.
Severe: feel restless in menstrual period or unbearably, have a strong impact on work and study or daily life, must lie up through front and back lower abdomen pain, ache with waist, complexion white, dripping cold sweat, extreme cold of the limbs, the vomiting abdomen is cold, or rectal tenesmus, adopts the pain relieving measure not have obvious alleviation.The dysmenorrhea symptom integral is more than 14 minutes.
Observation index; Adopt " the clinical research guideline of treatment by Chinese herbs dysmenorrhea " observation index as Comparison of therapeutic and the fractionated observation index of dysmenorrhea light and heavy degree before and after the treatment.
4. Therapeutic Method
Each menstrual cycle a few days ago begin treatment of hanging oneself.Every day, potion was decocted in water for oral dose, every day 2 times, and logotype five days, treating 3 menstrual cycle continuously is 1 course of treatment.
5. clinical efficacy
5.1 efficacy assessment standard
Formulate according to " the clinical research guideline of new Chinese medicine treatment dysmenorrhea " in Ministry of Health of the People's Republic of China's " new Chinese medicine clinical research guideline ":
Recent clinical cure: take medicine back stomachache and other transference cure, 3 menstrual cycle of drug withdrawal do not recur, and pain degree recovers 0 fen person.
Produce effects: stomachache obviously alleviates, and all the other transference cures or alleviate refuse to obey that analgesic can adhere to work, and pain degree is reduced to below 1/2 of integration of treatment for the treatment integration.
Effectively: stomachache alleviates, and all the other symptoms take a turn for the better, and the clothes analgesic can be adhered to work; Pain degree is reduced to preceding below 1/3 of integration of treatment for treatment back integration.
Invalid: stomachache and other symptom do not have the changer.
5.2 therapeutic outcome:
In order to 3 menstrual cycle of last scheme treatment, treat 180 routine dysmenorrhea patients, cure rate 80.00%, effective percentage 96.67%.Follow up a case by regular visits to 1 year dysmenorrhea and do not recur, the treatment situation sees the following form:
| Calibration | The example number | Cure | Produce effects | Effectively | Invalid | Effective percentage |
| Slightly | 72 | 66 | 6 | 0 | 0 | 100％ |
| Moderate | 78 | 63 | 6 | 6 | 3 | 96.15％ |
| Severe | 30 | 15 | 6 | 6 | 3 | 90.00％ |
| Add up to | 180 | 144 | 18 | 12 | 6 | 96.67％ |
Clinical research is the result show: evident in efficacy with prescription therapeutic primary dysmenorrhea of the present invention, and have no side effect.
The specific embodiment
The following examples can make those skilled in the art more fully understand the present invention, but do not limit the present invention in any way.
Embodiment 1
Take by weighing each crude drug by following weight proportion:
Radix Angelicae Sinensis 10g, Rhizoma Cyperi 30g, Lignum Sappan 10g, Caulis Spatholobi 10g,
Semen Persicae 10g, Rhizoma Corydalis 15g, Radix Paeoniae Rubra 10g, Rhizoma Zingiberis Recens 10g,
Ramulus Cinnamomi 6g, Folium Artemisiae Argyi 6g, Fructus Crataegi 10g, Radix Curcumae 6g and Flos Caryophylli 6g,
Add 500 milliliters of slow fire of water and fry in shallow oil half an hour slowly, get supernatant.Other gets Radix Notoginseng 10 grams and is ground into fine powder, and other wraps stand-by.
Using method: a few days ago begin to take in each menstrual cycle, potion clear water decoction every day, sooner or later respectively once.Get the supernatant Radix Notoginseng powder of taking after mixing it with water when taking, serve on five days and get final product.
Embodiment 2
Take by weighing each crude drug by following weight proportion:
Radix Angelicae Sinensis 5g, Rhizoma Cyperi 40g, Lignum Sappan 5g, Caulis Spatholobi 20g,
Semen Persicae 5g, Rhizoma Corydalis 20g, Radix Paeoniae Rubra 5g, Rhizoma Zingiberis Recens 15g,
Ramulus Cinnamomi 3g, Folium Artemisiae Argyi 12g, Fructus Crataegi 10g, Radix Curcumae 9g and Flos Caryophylli 3g,
Add 500 milliliters of slow fire of water and fry in shallow oil half an hour slowly, get supernatant.Other gets Radix Notoginseng 5-25 gram and is ground into fine powder, and other wraps stand-by.
Embodiment 3
Take by weighing each crude drug by following weight proportion:
Radix Angelicae Sinensis 15g, Rhizoma Cyperi 20g, Lignum Sappan 15g, Caulis Spatholobi 10g,
Semen Persicae 15g, Rhizoma Corydalis 10g, Radix Paeoniae Rubra 15g, Rhizoma Zingiberis Recens 10g,
Ramulus Cinnamomi 9g, Folium Artemisiae Argyi 5g, Fructus Crataegi 20g, Radix Curcumae 3g and Flos Caryophylli 9g,
Add 500 milliliters of slow fire of water and fry in shallow oil half an hour slowly, get supernatant.Other gets Radix Notoginseng 5-25 gram and is ground into fine powder, and other wraps stand-by.
Claims (2)
1. medicine for the treatment of primary dysmenorrhea is characterized in that medical material in the raw material is formed and the weight portion proportioning is:
Radix Angelicae Sinensis 5-15 part, Rhizoma Cyperi 20-40 part, Lignum Sappan 5-15 part, Caulis Spatholobi 10-20 part, Semen Persicae 5-15 part, Rhizoma Corydalis 10-20 part, Radix Paeoniae Rubra 5-15 part, Rhizoma Zingiberis Recens 10-15 part, Radix Notoginseng 5-25 part, Folium Artemisiae Argyi 5-12 part, Fructus Crataegi 10-20 part, Radix Curcumae 3-9 part, Ramulus Cinnamomi 3-9 part and Flos Caryophylli 3-9 part.
2. according to the medicine of the described treatment primary dysmenorrhea of claim 1, it is characterized in that medical material composition and the weight portion proportioning in the raw material is:
6 parts of 10 parts of Radix Angelicae Sinensis, 30 parts of Rhizoma Cyperis, 10 parts of Lignum Sappans, 10 parts of Caulis Spatholobis, 10 parts in Semen Persicae, 15 parts of Rhizoma Corydalis, 10 parts of Radix Paeoniae Rubra, 10 parts in Rhizoma Zingiberis Recens, 10 parts of Radix Notoginseng, 6 parts of Folium Artemisiae Argyis, 10 parts of Fructus Crataegis, 6 parts of Radix Curcumaes, 6 parts of Ramulus Cinnamomi and Flos Caryophyllis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010149096XA CN101804189B (en) | 2010-04-14 | 2010-04-14 | Drug for treating primary dysmenorrhea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010149096XA CN101804189B (en) | 2010-04-14 | 2010-04-14 | Drug for treating primary dysmenorrhea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101804189A CN101804189A (en) | 2010-08-18 |
| CN101804189B true CN101804189B (en) | 2011-09-07 |
Family
ID=42606249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201010149096XA Expired - Fee Related CN101804189B (en) | 2010-04-14 | 2010-04-14 | Drug for treating primary dysmenorrhea |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101804189B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102688458B (en) * | 2012-06-10 | 2013-09-25 | 李百荣 | Chinese medicament for treating primary dysmenorrhea |
| CN105126044A (en) * | 2015-10-28 | 2015-12-09 | 王淑英 | Medicine for treating primary dysmenorrheal |
| CN105497389A (en) * | 2016-01-31 | 2016-04-20 | 济南新时代医药科技有限公司 | Traditional Chinese medicine for treating primary dysmenorrhea |
| CN111494347A (en) * | 2020-04-12 | 2020-08-07 | 沈阳促晋科技有限公司 | Traditional Chinese medicine plaster for treating dysmenorrhea and preparation method thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100490891C (en) * | 2006-06-13 | 2009-05-27 | 厦门桂龙投资管理有限公司 | Medicine composition for treating dysmenorrhea and its preparation process |
-
2010
- 2010-04-14 CN CN201010149096XA patent/CN101804189B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101804189A (en) | 2010-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103933468A (en) | Traditional Chinese medicine for treating acute pancreatitis | |
| CN102580000B (en) | Medicament for curing cancer pain and preparation method thereof | |
| CN101804189B (en) | Drug for treating primary dysmenorrhea | |
| CN103495055A (en) | Traditional Chinese medicine decoction for treating female endocrine disorders and preparation method thereof | |
| CN103585591A (en) | Traditional Chinese medicine for treating gallstones | |
| CN105639005A (en) | Russula sanguinaria health tea and preparation method thereof | |
| CN103100035B (en) | Traditional Chinese medicine (TCM) decoction for treating globus hysteriocus | |
| CN102488795B (en) | Medicine for treating radiation dermatitis after head neck radiotheraphy | |
| CN105853930A (en) | Traditional Chinese medicine composition for treating depression | |
| CN105770748A (en) | Traditional Chinese medicine composition for treating gouts | |
| CN105641419A (en) | Traditional Chinese medicine composition for treating Yin deficiency type cough caused by lung cancer | |
| CN105233078A (en) | Traditional Chinese medicine composition for treating viral hepatitis | |
| CN104398958A (en) | Tablet for treating leukemia | |
| CN104587389A (en) | Traditional Chinese medicine composition for treating neck shoulder pain and lumbocrural pain | |
| CN101502597B (en) | Medicament for treating stomachache and preparation method thereof | |
| CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
| CN104173913A (en) | Traditional Chinese medicine for treating chronic cholecystitis | |
| CN102727773A (en) | Traditional Chinese medicinal capsule for treating blood mucoviscidosis | |
| CN110841007B (en) | Traditional Chinese medicine composition for treating cerebral apoplexy sequela and application thereof | |
| CN101912566B (en) | Traditional Chinese medicine for treating palpitation | |
| CN105232609A (en) | Traditional Chinese medicine combination treating functional dyspepsia | |
| CN105412378A (en) | Traditional Chinese medicine composition for treating hyperostosis and cervical spondylosis | |
| CN104623333A (en) | Drug for treating facial paralysis | |
| CN105169111A (en) | Traditional Chinese medicine composition for treating chronic urticaria and application of traditional Chinese medicine composition | |
| CN104758346A (en) | Medicine for treating migraine, as well as preparation method and preparation of medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110907 Termination date: 20130414 |